Lim Research Group

Publications

  1. Lim, S. (2023). Pilot Study of Immune Response and Iatrogenic Withdrawal Syndrome in Critically-Ill Children Receiving Fentanyl Infusion. . Am J Pharm Educ, 87(8), 100158.
  2. Lim, S. (2021). Opioid effects on the central nervous system and the peripheral immune system: implications for opioid tolerance. Current Pharmacology Reports. https://doi.org/https://doi.org/10.1007/s40495-021-00258-5
  3. Harkin, M., Miller, J. L., Lim, S., Neely, S., Walsh, C., & Johnson, P. N. (2021). Conversion from Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Annals of Pharmacotherapy.
  4. Lim, S., Lewis, T. V., Woo, S., Bourne, D. A., Burton, M. E., Turman, M. A., & Rianthavorn, P. (2021). Daptomycin pharmacokinetics in adolescents undergoing hemodialysis and peritoneal dialysis: a case series with pharmacokinetic modeling. The Journal of Pediatric Pharmacology and Therapeutics, 26(2), 123-132. https://doi.org/10.5863/1551-6776-26.2.123
  5. Lim, S. (2021). Iatrogenic withdrawal syndrome in children transitioning from fentanyl infusion to methadone. Critical Care Medicine, 49(1), 429. https://doi.org/10.1097/01.ccm.0000729344.11098.b2
  6. Lim, S., & Miller, J. L. (2020). Ampicillin dose for early and late-onset Group B Streptococcal disease in neonates. American Journal of Perinatology(Online ahead of print). https://doi.org/10.1055/s-0040-1718880
  7. Lim, S., Sharan, S., & Woo, S. (2020). Model-based meta-analysis of cannabidiol dose-exposure relationship and bioavailability. Pharmacotherapy. https://doi.org/10.1002/phar.2377